These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33347989)

  • 21. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    Wu S; Tian C; Liu P; Guo D; Zheng W; Huang X; Zhang Y; Liu L
    J Med Virol; 2021 Apr; 93(4):2132-2140. PubMed ID: 33090512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a Polymorphism in the N Gene of SARS-CoV-2 That Adversely Impacts Detection by Reverse Transcription-PCR.
    Vanaerschot M; Mann SA; Webber JT; Kamm J; Bell SM; Bell J; Hong SN; Nguyen MP; Chan LY; Bhatt KD; Tan M; Detweiler AM; Espinosa A; Wu W; Batson J; Dynerman D; Wadford DA; Puschnik AS; Neff N; Ahyong V; Miller S; Ayscue P; Tato CM; Paul S; Kistler AL; DeRisi JL; Crawford ED
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33067272
    [No Abstract]   [Full Text] [Related]  

  • 24. SARS-Cov-2 ORF3a: Mutability and function.
    Bianchi M; Borsetti A; Ciccozzi M; Pascarella S
    Int J Biol Macromol; 2021 Feb; 170():820-826. PubMed ID: 33359807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic.
    Anwar MZ; Lodhi MS; Khan MT; Khan MI; Sharif S
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein.
    Pal A; Dobhal S; Dey KK; Sharma AK; Savani V; Negi VS
    Comput Biol Chem; 2021 Dec; 95():107594. PubMed ID: 34736125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology.
    Hamed SM; Elkhatib WF; Khairalla AS; Noreddin AM
    Sci Rep; 2021 Apr; 11(1):8435. PubMed ID: 33875719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping the Nonstructural Transmembrane Proteins of Severe Acute Respiratory Syndrome Coronavirus 2.
    Thomas S
    J Comput Biol; 2021 Sep; 28(9):909-921. PubMed ID: 34182794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
    Rahman MS; Islam MR; Alam ASMRU; Islam I; Hoque MN; Akter S; Rahaman MM; Sultana M; Hossain MA
    J Med Virol; 2021 Apr; 93(4):2177-2195. PubMed ID: 33095454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global landscape of SARS-CoV-2 mutations and conserved regions.
    Abbasian MH; Mahmanzar M; Rahimian K; Mahdavi B; Tokhanbigli S; Moradi B; Sisakht MM; Deng Y
    J Transl Med; 2023 Feb; 21(1):152. PubMed ID: 36841805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13.
    Akaishi T
    Microbiol Spectr; 2022 Jun; 10(3):e0071622. PubMed ID: 35658573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.
    Yoshimoto FK
    Protein J; 2020 Jun; 39(3):198-216. PubMed ID: 32447571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.
    Chowdhury UF; Sharif Shohan MU; Hoque KI; Beg MA; Sharif Siam MK; Moni MA
    Genomics; 2021 Jan; 113(1 Pt 1):331-343. PubMed ID: 33321203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.
    Chan WM; Ip JD; Chu AW; Yip CC; Lo LS; Chan KH; Ng AC; Poon RW; To WK; Tsang OT; Leung WS; Kwan MY; Chua GT; Chung TW; Hung IF; Kok KH; Cheng VC; Chan JF; Yuen KY; To KK
    J Med Virol; 2020 Nov; 92(11):2725-2734. PubMed ID: 32501535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates.
    Prathiviraj R; Chellapandi P; Begum A; Kiran GS; Selvin J
    Virus Res; 2022 Jan; 307():198618. PubMed ID: 34740719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System.
    Raheja H; Das S; Banerjee A; P D; C D; Mukhopadhyay D; Ramachandra SG; Das S
    Microbiol Spectr; 2022 Aug; 10(4):e0078122. PubMed ID: 35862952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The global population of SARS-CoV-2 is composed of six major subtypes.
    Morais IJ; Polveiro RC; Souza GM; Bortolin DI; Sassaki FT; Lima ATM
    Sci Rep; 2020 Oct; 10(1):18289. PubMed ID: 33106569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.